Data availability
Upon request, and subject to certain criteria, conditions and exceptions, Astellas will provide access to anonymized patient-level data from completed Astellas-sponsored phase 1 to phase 4 interventional clinical studies conducted for products and indications that have been approved in any country and also for studies conducted for terminated compounds. Approval must have been granted by the agencies of the main regions: the USA the European Union and Japan. If approval is sought in only one or two regions, approval must have been granted by those agencies. Where available, the following anonymized patient-level data and information are provided for each clinical study: raw dataset, analysis-ready dataset, protocols with any amendments or addenda, annotated case report form, statistical analysis plan, dataset specifications and clinical study report. Additionally, data may be available upon reasonable request. Researchers may request access to anonymized participant-level data, trial-level data and protocols from Astellas-sponsored clinical trials at 